Clinical trial
Randomized Phase II Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer Patients
NCT01096745 is registered in ClinicalTrials.gov with Gyeongsang National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase II Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer Patients
- Lead sponsor
- Gyeongsang National University Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2010
- Completion date
- September 30, 2013
- Enrollment
- 78 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced biliary tract cancer, metastatic biliary tract cancer